Company Valuation: Valiant Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2024 2025 2026
Market Cap 1 6,302 3,327 2,804
Change - -47.2% -15.74%
Enterprise Value (EV) 1 5,631 3,780 2,934
Change - -32.87% -22.38%
P/E 1,725x -150x -79.4x
PBR 2.66x 1.42x 0.9x
PEG -17.4x 0x -2.9x
Capitalization / Revenue 3.46x 2.49x 1.18x
EV / Revenue 3.09x 2.83x 1.24x
EV / EBITDA -65.5x -77.6x 43.2x
EV / EBIT -54.3x -55.8x 303x
EV / FCF -14.1x -2.79x -6.1x
FCF Yield -7.11% -35.9% -16.4%
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 0.0841 -0.51 -0.65
Distribution rate - - -
Net sales 1 1,821 1,334 2,375
EBITDA 1 -85.98 -48.7 67.99
EBIT 1 -103.7 -67.72 9.695
Net income 1 3.196 -22.01 -32.68
Net Debt 1 -671.1 452.9 130.6
Reference price 2 145.05 76.58 51.62
Nbr of stocks (in thousands) 43,450 43,450 54,313
Announcement Date 17/07/24 01/09/25 03/09/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 73.19M
39.81x5.37x21.86x0.97% 84.34B
33.9x5.12x21.9x1.89% 43.75B
24.23x2.87x15.02x2.16% 34.63B
15.4x1.6x8.95x2.72% 33.66B
39.5x7.1x18.82x1.57% 32.38B
14.82x1.41x8.73x2.15% 26.34B
39.37x9.54x29.25x2.26% 23.89B
26.39x2.84x11.55x1.7% 18.98B
7.64x2.16x4.3x3.43% 16.1B
Average 26.78x 4.22x 15.60x 2.09% 31.41B
Weighted average by Cap. 30.03x 4.50x 17.35x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Valiant Laboratories Limited

Historical PBR trend

Valuation ratios - PBR - Valiant Laboratories Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Valiant Laboratories Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Valiant Laboratories Limited

  1. Stock Market
  2. Stocks
  3. VALIANTLAB Stock
  4. Valuation Valiant Laboratories Limited